Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD
The project targets patients with refractory IBD who lack effective options; a new allogeneic stromal cell therapy could expand treatment choices for people who fail multiple drugs. The work focuses on immune pathways...